Results 1 to 10 of about 50,612 (311)

Successful orthotopic liver transplantation in an adult patient with sickle cell disease and review of the literature [PDF]

open access: yesHematology Reports, 2013
Sickle cell disease can lead to hepatic complications ranging from acute hepatic crises to chronic liver disease including intrahepatic cholestasis, and iron overload.
Morey Blinder   +7 more
doaj   +3 more sources

Orthotopic Liver Transplantation in Familial Amyloidotic Polyneuropathy Is Associated with Long-Term Progression of Renal Disease [PDF]

open access: green, 2012
Orthotopic liver transplantation has become the treatment of choice for familial amyloidotic polyneuropathy. The aims of this study were to evaluate the renal complications post orthotopic liver transplantation in familial amyloidotic polyneuropathy and
Baptista, A   +6 more
core   +2 more sources

Abnormal hemostatic function one year after orthotopic liver transplantation can be fully attributed to endothelial cell activation [v2; ref status: indexed, http://f1000r.es/40n] [PDF]

open access: goldF1000Research, 2014
Background: The long-term risk of thrombotic and vascular complications is elevated in liver transplant recipients compared to the general population.
Freeha Arshad   +5 more
doaj   +2 more sources

Orthotopic Liver Transplantation in a Patient With <i>GALT</i>p.Ser135Leu/Null. [PDF]

open access: goldJIMD Rep
Simpson K   +7 more
europepmc   +3 more sources

Effect of SABP, A Water-soluble Component of Salvia Miltiorrhiza, on Immune Microenvironment of Mice with Liver Cancer

open access: yesZhongliu Fangzhi Yanjiu, 2021
Objective To investigate the effect of SABP, a water-soluble component of Salvia miltiorrhiza, on the growth of orthotopic transplantation of H22 liver cancer and the immune microenvironment of liver cancer.
LI Shenghao   +5 more
doaj   +1 more source

Protein C in a patient with portal vein thrombosis in liver transplantation

open access: yesТрансплантология (Москва), 2021
Background. The problem of thromboses, including those associated with impaired hemostasis system, is relevant in orthotopic liver transplantation.Aim. To present the experience of intraoperative use of protein C during orthotopic liver transplantation ...
S. V. Zhuravel   +4 more
doaj   +1 more source

Aprotinin in Orthotopic Liver Transplantation [PDF]

open access: yesSeminars in Thrombosis and Hemostasis, 1993
Aprotinin is a protease inhibitor isolated from bovine lungs and othcr lissues. Its biochcmical struc!Urc, a single-chain polypeptide of 6.5 12 kD , and biophysical properties are weH defined. I The activity of commcrcial preparations of apralini n is usually describcd in kallikrein inac ti valor unils (KIU) , 0. 1 million KIU being equivalent 102.
Bechstein, W. O.   +8 more
openaire   +3 more sources

Orthotopic Liver Transplantation in Rats [PDF]

open access: yesJournal of Visualized Experiments, 2012
Clinical progress in the field of liver transplantation has been largely supported by animal models(1,2). Since the publication of the first orthotopic rat liver transplantation in 1979 by Kamada et al.(3), this model has remained the gold standard despite various proposed alternative techniques(4). Nevertheless, its broader use is limited by its steep
Oldani, Graziano   +4 more
openaire   +3 more sources

Recurrent and de novo non-alcoholic steatohepatitis following orthotopic liver transplantation [PDF]

open access: yesArquivos de Gastroenterologia, 2001
Background — Non-alcoholic steatohepatitis was coined in 1980 to describe pathological and clinical features of non-alcoholic disease associated with pathological features, commonly seen in alcoholic-liver disease itself.
Raquel F. Liermann GARCIA   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy